Sylvia A. Ashamallah

Al Mansurah, DK, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

CRE26-063: T-Cell Lymphoblastic Lymphoma in Pregnancy Managed With the Augmented-BFM* Protocol: A Case Report and Literature Review (*Berlin-Frankfurt-Münster).

CRE26-063: T-Cell Lymphoblastic Lymphoma in Pregnancy Managed With the Augmented-BFM* Protocol: A Case Report and Literature Review (*Berlin-Frankfurt-Münster).

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

CRE26-063: T-Cell Lymphoblastic Lymphoma in Pregnancy Managed With the Augmented-BFM* Protocol: A Case Report and Literature Review (*Berlin-Frankfurt-Münster).

CRE26-063: T-Cell Lymphoblastic Lymphoma in Pregnancy Managed With the Augmented-BFM* Protocol: A Case Report and Literature Review (*Berlin-Frankfurt-Münster).

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

Correlation of PD-L1 immunohistochemical expression with microsatellite instability and p53 status in endometrial carcinoma.

Correlation of PD-L1 immunohistochemical expression with microsatellite instability and p53 status in endometrial carcinoma.

Journal: European journal of obstetrics & gynecology and reproductive biology: X

Published: July 02, 2022

Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice.

Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice.

Journal: Stem cell research & therapy

Published: March 05, 2022

PRDX6 Promotes the Differentiation of Human Mesenchymal Stem (Stromal) Cells to Insulin-Producing Cells.

PRDX6 Promotes the Differentiation of Human Mesenchymal Stem (Stromal) Cells to Insulin-Producing Cells.

Journal: BioMed research international

Published: May 12, 2019

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma.

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma.

Journal: Journal of pathology and translational medicine

Published: August 31, 2018

Insulin-producing Cells from Adult Human Bone Marrow Mesenchymal Stromal Cells Could Control Chemically Induced Diabetes in Dogs: A Preliminary Study.

Insulin-producing Cells from Adult Human Bone Marrow Mesenchymal Stromal Cells Could Control Chemically Induced Diabetes in Dogs: A Preliminary Study.

Journal: Cell transplantation

Published: June 05, 2018

From Human Mesenchymal Stem Cells to Insulin-Producing Cells: Comparison between Bone Marrow- and Adipose Tissue-Derived Cells.

From Human Mesenchymal Stem Cells to Insulin-Producing Cells: Comparison between Bone Marrow- and Adipose Tissue-Derived Cells.

Journal: BioMed research international

Published: February 24, 2017

The novel c-Met inhibitor capmatinib mitigates diethylnitrosamine acute liver injury in mice.

The novel c-Met inhibitor capmatinib mitigates diethylnitrosamine acute liver injury in mice.

Journal: Toxicology letters

Published: July 19, 2016

Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity.

Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Published: January 15, 2016

Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo.

Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo.

Journal: BioMed research international

Published: November 05, 2014

The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms.

The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms.

Journal: Chemico-biological interactions

Published: April 15, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026